Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5,816 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Regolazione del prezzo e rimborso dei farmaci: comparatori, endpoint e ruolo della costo-efficacia.
Jommi C, Apolone G, Scroccaro G, Acciai V, Addis A, Ardizzoni A, Bernardini R, Bortolami A, Brigido A, Buzzetti G, Canonico PL, Caprari F, Centanni S, Cernetti C, Cicchetti A, Corsico G, Damele F, de Braud F, Manurita S, Mennini FS, Olivi I, Parretta F, Pippo L, Pulimeno S, Riccaboni M, Rossi G, Saleri C, Sinibaldi A, Spandonaro F, Stefenoni C, Visentin E, Viale P, Zapparelli G, Popoli P. Jommi C, et al. Among authors: rossi g. Glob Reg Health Technol Assess. 2022 Sep 28;9:99-104. doi: 10.33393/grhta.2022.2475. eCollection 2022 Jan-Dec. Glob Reg Health Technol Assess. 2022. PMID: 36628317 Free PMC article. Italian.
[Unmet clinical need and new therapeutic options.].
Caprari F, Alfano A, Buzzetti G, Consoli A, de Braud F, Patarnello F, Pitrelli A, Riccaboni M, Rossi G, Samele R, Scaduto D, Viale P, Jommi C, Popoli P. Caprari F, et al. Among authors: rossi g. Recenti Prog Med. 2022 Mar;113(3):161-166. doi: 10.1701/3761.37480. Recenti Prog Med. 2022. PMID: 35315445 Italian.
Assessing eligibility for treatment in acute myeloid leukemia in 2023.
Venditti A, Cairoli R, Caira M, Finsinger P, Finocchiaro F, Neri B, De Benedittis D, Rossi G, Ferrara F. Venditti A, et al. Among authors: rossi g. Expert Rev Hematol. 2023 Mar;16(3):181-190. doi: 10.1080/17474086.2023.2185603. Epub 2023 Mar 8. Expert Rev Hematol. 2023. PMID: 36876439 Free article. Review.
Improved overall survival in patients developing endocrine toxicity during treatment with nivolumab for advanced non-small cell lung cancer in a prospective study.
Albertelli M, Rossi G, Nazzari E, Genova C, Biello F, Rijavec E, Dal Bello MG, Patti L, Tagliamento M, Barletta G, Morabito P, Boschetti M, Dotto A, Campana D, Ferone D, Grossi F. Albertelli M, et al. Among authors: rossi g. J Endocrinol Invest. 2024 Apr 29. doi: 10.1007/s40618-023-02268-0. Online ahead of print. J Endocrinol Invest. 2024. PMID: 38683497
CXCL9 and CXCL10 as biomarkers of kidney graft inflammation across multiple conditions.
Gandolfini I, Mordà B, Martinelli E, Delsante M, Rossi G, Gentile M, Alibrandi S, Salvetti D, Fiaccadori E, Palmisano A, Cravedi P, Maggiore U. Gandolfini I, et al. Among authors: rossi g. Clin Transplant. 2024 May;38(5):e15324. doi: 10.1111/ctr.15324. Clin Transplant. 2024. PMID: 38678588 No abstract available.
BAP1 Loss, Nuclear Grading, and Nonepithelioid Features in the Diagnosis of Mesothelioma in Italy: Nevermore without the Pathology Report.
Rossi G, Righi L, Barbisan F, Tiseo M, Spagnolo P, Grosso F, Pisapia P, Malapelle U, Sculco M, Dianzani I, Abate-Daga L, Davolio MC, Ceresoli GL, Galetta D, Pasello G, Novello S, Bironzo P. Rossi G, et al. J Pers Med. 2024 Apr 8;14(4):394. doi: 10.3390/jpm14040394. J Pers Med. 2024. PMID: 38673021 Free PMC article. Review.
5,816 results